MENU
+Compare
MET
Stock ticker: NYSE
AS OF
Apr 1, 04:59 PM (EDT)
Price
$81.19
Change
+$0.90 (+1.12%)
Capitalization
53.28B

MET MetLife Forecast, Technical & Fundamental Analysis

MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products... Show more

MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MET with price predictions
Mar 31, 2025

MET sees MACD Histogram just turned negative

MET saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on March 31, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MET as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MET moved below its 50-day moving average on March 27, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MET broke above its upper Bollinger Band on February 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MET entered a downward trend on February 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MET advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.775) is normal, around the industry mean (1.496). P/E Ratio (40.713) is within average values for comparable stocks, (39.438). MET's Projected Growth (PEG Ratio) (0.111) is slightly lower than the industry average of (0.675). Dividend Yield (0.028) settles around the average of (0.124) among similar stocks. P/S Ratio (0.846) is also within normal values, averaging (2.172).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MET is expected to report earnings to fall 1.44% to $2.06 per share on April 30

MetLife MET Stock Earnings Reports
Q1'25
Est.
$2.06
Q4'24
Est.
$2.09
Q3'24
Missed
by $0.24
Q2'24
Beat
by $0.18
Q1'24
Missed
by $0.03
The last earnings report on February 05 showed earnings per share of $2.09, meeting the estimate of $2.09. With 833.27K shares outstanding, the current market capitalization sits at 53.28B.
A.I.Advisor
published Dividends

MET paid dividends on March 11, 2025

MetLife MET Stock Dividends
А dividend of $0.55 per share was paid with a record date of March 11, 2025, and an ex-dividend date of February 04, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of insurance and financial services and also function as bank holding company

Industry LifeHealthInsurance

Profile
Fundamentals
Details
Industry
Life Or Health Insurance
Address
200 Park Avenue
Phone
+1 212 578-9500
Employees
45000
Web
https://www.metlife.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MKL1869.6114.17
+0.76%
Markel Group
BPRN30.55-0.01
-0.03%
Princeton Bancorp
CBRL38.82-1.20
-3.00%
Cracker Barrel Old Country Store
AKRO40.48-2.24
-5.24%
Akero Therapeutics
CARM0.31-0.02
-6.06%
Carisma Therapeutics

MET and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
+1.34%
PRU - MET
87%
Closely correlated
+1.46%
AFL - MET
86%
Closely correlated
+1.27%
CNO - MET
71%
Closely correlated
+0.41%
LNC - MET
70%
Closely correlated
+0.64%
JXN - MET
66%
Closely correlated
+0.78%
More

Groups containing MET

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
+1.34%
MET
(6 stocks)
89%
Closely correlated
+0.63%